Extended Data Fig. 2: Antigen-capturing bacteria improve immune responses and trigger abscopal effects in CT26-tumour-bearing mice.

a, Schematic of the therapeutic treatments for inhibiting the growth of primary and re-challenged CT26 tumours. Irradiated tumours are indicated as ‘primary tumour’ and were treated with antigen-capturing bacteria, and the re-challenged tumours are labelled as ‘secondary tumour’ and were not treated. b,c, Average tumour growth curves of primary (b, n = 10, biologically independent animals) and secondary CT26 tumours (c) post-treatment. d, Representative photographs of the CT26 tumours 32 days after the corresponding treatments. For the experiments in b and c, data are the mean ± s.e.m. Statistical significance was determined by a two-way ANOVA with Tukey’s multiple comparisons test.